Report Highlights
The global market for cognitive computing and AI systems in healthcare should reach $16.1 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 45.9% for the period of 2017 to 2022.
Report Includes
- 51 data tables and 39 additional tables
- An overview of the global market for cognitive computing and artificial intelligence systems in healthcare
- Analyses of market trends, with data from 2016 to 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Identification of key market segments and market structure in cognitive computing and artificial intelligence systems in healthcare technologies
- Coverage of major stakeholders, product portfolio and recent developments
- Examination of competitive landscape for the market leaders
- Information on the trends, gaps and opportunities that will impact the future market
- Company profiles of major players in the market, including Alphabet Inc., Apple Inc., General Vision, IBM, Microsoft Corp., Oncora Medical and Welltok Inc.
Report Scope
This research report presents an in-depth analysis of the global market for cognitive computing and artificial intelligence systems in healthcare by offering, technology, application, end users and geographic markets. The report includes key factors driving growth of cognitive computing and artificial intelligence systems in healthcare. The report discusses the role of supply chain members ranging from manufacturers to researchers. The report has an in-depth analysis of key companies operating in the global market for cognitive computing and artificial intelligence systems in healthcare. The report’s in-depth patent analysis will focus on providing extensive technological trends across years and geographies such as the U.S., Europe and China.
The market for cognitive computing and artificial intelligence systems in healthcare is mainly segmented into five major components: type of offering, technology, application, end user and geography. Based on offering, the market is segmented into hardware, software and services. Based on technology, the market is categorized into natural language processing, context aware processing, deep learning and querying method. The market is classified by applications into robot-assisted surgery, preliminary diagnosis, clinical trial participant identifier, dosage error reduction, virtual nursing assistant, administrative workflow assistance, fraud detection and others. Based on end users, the market is divided into healthcare provider, pharmaceutical and biotechnology company, patient and payer. The market is segmented by region into the North America, Europe, Asia-Pacific and ROW.
Analyst Credentials
Sangeeta Rai is a senior researcher who has analyzed and forecasted healthcare and advanced chemicals markets since 2011. She holds a Bachelor of Science in biotechnology and a Master of Business Administration in marketing. Prior to joining BCC Research, she has held senior research roles at Global Data and Infinity Research. Sangeeta Rai is a pseudonym of the author.
Related Reports
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Internet of Things (IoT) Sensors in Healthcare: Global Markets and Technologies
The global market for internet of things (IoT) sensors in healthcare is estimated to increase from $2.9 billion in 2023 to reach $8.6 billion by 2028, at a compound annual growth rate (CAGR) of 24.6% from 2023 through 2028.
Artificial Intelligence in Fintech Market: Global Analysis and Growth Forecast to 2027
The global artificial intelligence (AI) in fintech market should reach $42.0 billion by 2027 from $14.7 billion in 2022 at a compound annual growth rate (CAGR) of 23.4% for the forecast period of 2022 to 2027.
4D Imaging in Healthcare
The global market for 4D imaging in healthcare is estimated to grow from $8.1 billion in 2022 to $16.7 billion in 2027, with a compound annual growth rate (CAGR) of 15.3% for the period of 2022-2027.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More